Olaf Hoffmann

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study

Karl Georg Hæusler, Paulus Kirchhof, Claudia Kunze et al. · The Lancet Neurology · 2021 · 92 citations · Full text

Amyloid β Peptide and Precursor Protein (APP) in Mild and Severe Brain Ischemia

K. Jendroska, Olaf Hoffmann, Stephan Patt · Annals of the New York Academy of Sciences · 1997 · 79 citations

Neurodegenerative Diseases, Precursor Protein, Ischemic Stroke +14

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis

Corinna Preuße, Yves Allenbach, Olaf Hoffmann et al. · Acta Neuropathologica Communications · 2016 · 70 citations · Full text

Monitoring of Venous Hemodynamics in Patients With Cerebral Venous Thrombosis by Transcranial Doppler Ultrasound

José M. Valdueza, Olaf Hoffmann, Markus Weih et al. · Archives of Neurology · 1999 · 61 citations